APA (7th ed.) Citation

Visani, G., Isidori, A., Malagola, M., Alberti, D., Capdeville, R., Martinelli, G., . . . Baccarani, M. (2002). Efficacy of imatinib mesylate (STI571) in conjunction with alpha-interferon: Long-term quantitative molecular remission in relapsed P-190(BCR-ABL)-positive acute lymphoblastic leukemia. Leukemia (08876924), 16(10), 2159. https://doi.org/10.1038/sj.leu.2402729

Chicago Style (17th ed.) Citation

Visani, G., et al. "Efficacy of Imatinib Mesylate (STI571) in Conjunction with Alpha-interferon: Long-term Quantitative Molecular Remission in Relapsed P-190(BCR-ABL)-positive Acute Lymphoblastic Leukemia." Leukemia (08876924) 16, no. 10 (2002): 2159. https://doi.org/10.1038/sj.leu.2402729.

MLA (9th ed.) Citation

Visani, G., et al. "Efficacy of Imatinib Mesylate (STI571) in Conjunction with Alpha-interferon: Long-term Quantitative Molecular Remission in Relapsed P-190(BCR-ABL)-positive Acute Lymphoblastic Leukemia." Leukemia (08876924), vol. 16, no. 10, 2002, p. 2159, https://doi.org/10.1038/sj.leu.2402729.